...
首页> 外文期刊>Annals of hematology >Reduced intensity conditioning allogeneic hematopoietic stem cell transplant could be beneficial to angioimmunoblastic T-cell lymphoma patients with hemophagocytic lymphohistiocytosis.
【24h】

Reduced intensity conditioning allogeneic hematopoietic stem cell transplant could be beneficial to angioimmunoblastic T-cell lymphoma patients with hemophagocytic lymphohistiocytosis.

机译:降低强度条件的异基因造血干细胞移植可能对血管吞噬T细胞淋巴瘤伴吞噬性淋巴细胞组织细胞增多症患者有益。

获取原文
获取原文并翻译 | 示例
           

摘要

T-cell non-Hodgkin's lymphomas (NHLs) are a group of heterogeneous diseases with more aggressive behavior and dismal outcome than B-cell NHLs and account for less than 10% of the cases of aggressive NHLs in Western countries [1]. The outcome of T-cell NHL is even worse when it occurs in combination with hemophago-cytic lymphohistiocytosis (HLH); this combination presents with fever, cytopenia, liver dysfunction, hepatos-plenomegaly, hypertriglyceridemia, and hyperferritinemia [2, 3]. We report the case of a patient who had angioimmunoblastic T-cell lymphoma (AITL) and HLH and was successfully treated by allogeneic hematopoietic stem cell transplant (HSCT) with a reduced-intensity conditioning (RIC) regimen.
机译:T细胞非霍奇金淋巴瘤(NHL)是一类异质性疾病,其行为比B细胞NHL更具有侵略性和令人沮丧的结局,在西方国家中,侵袭性NHL病例不到10%[1]。当与吞噬细胞性淋巴组织细胞增生症(HLH)结合发生时,T细胞NHL的结果甚至更糟。这种组合表现为发烧,血细胞减少,肝功能障碍,肝脾肿大,高甘油三酯血症和高铁蛋白血症[2,3]。我们报告了一名患者,该患者患有血管免疫母细胞性T细胞淋巴瘤(AITL)和HLH,并已通过异体造血干细胞移植(HSCT)进行了降低强度的调节(RIC)方案成功治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号